TBK1 and amyotrophic lateral sclerosis: Weak: heterozygous LOF mutations in TBK1 have best evidence base in ALS, significance of missense mutations unclear. V464A variant located in scaffold dimerisation domain, whereas functional missense variants more likely to be in kinase domain [58]